Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

85 collaborators·134 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

M.D. Anderson Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

LeukemiaLymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score30%

Helen Heslop, MD

Baylor College of Medicine

Moderately Similar
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLeukemiaLymphoma
Similarity Score30%

Vincenzo Liso, MD

UO Universita degi Studi Policinico Ematologia

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Wendy Stock, MD

University of Chicago Hospital

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Vernon Louw, MD

Free State University

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Peter Staib, MD

Med. Klinik I / Hamatolgie

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Nicholas Novitzky, MD

Division of Haematology

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Gerhard Ehninger, MD

Klinikum Carl Gustav Carus der Technischen Universitat

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Belinda Pinto Simoes, MD

Hospital das Clinicas de Faculdade de Medicina de Ribeirao Preto

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00289549Phase 2PrincipalInvestigator

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

Leukemia, Lymphocytic, Chronic
Completed
NCT00419081Phase 2PrincipalInvestigator

Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens

LeukemiaLymphoma
Terminated

All 2 trials loaded